Related Experiment Video

Updated: Sep 4, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

755

Monitoring of paediatric type 1 diabetes

Brynn E Marks1, Joseph I Wolfsdorf2

  • 1Children's National Hospital, Division of Endocrinology, Washington, District of Columbia.

Current Opinion in Pediatrics
|July 15, 2022
PubMed

Insights

Continuous glucose monitoring (CGM) is the optimal method for monitoring glucose in children with type 1 diabetes (T1D). Early introduction and proper training are key to improving glycaemic control and outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Diabetes Technology
  • Metabolic Monitoring

Background:

  • Type 1 diabetes (T1D) management in children requires diligent monitoring of glycemia and ketones.
  • Traditional methods like glycated haemoglobin (HbA1c) have limitations for assessing individual glycemic control.
  • Technological advancements have significantly improved glucose monitoring methods.

Purpose of the Study:

  • To review recent developments in monitoring methods for pediatric type 1 diabetes.
  • To examine the role and limitations of HbA1c, self-monitoring of blood glucose, and ketone monitoring.
  • To highlight the advantages and recommended use of continuous glucose monitoring (CGM) systems.

Main Methods:

  • Review of current literature on pediatric T1D monitoring technologies.
  • Analysis of the efficacy and usability of various glucose monitoring techniques.
  • Evaluation of the role of CGM in optimizing glycemic control.

Main Results:

  • Continuous glucose monitoring (CGM) is now considered the optimal method for glucose monitoring in T1D.
  • Recent innovations have enhanced the accuracy and usability of CGM systems.
  • CGM should be introduced shortly after the diagnosis of T1D for improved management.

Conclusions:

  • Comprehensive education and training on CGM use and data interpretation are crucial for patients, families, and healthcare providers.
  • Ensuring equitable access to CGM technology is essential for improving T1D care.
  • Optimizing the clinical application of CGM holds promise for better T1D outcomes in children.
Abstract

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.9K

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
349
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
680
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
246
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K